Shinoda Takehiro, Shinya Naoko, Ito Kaori, Ishizuka-Katsura Yoshiko, Ohsawa Noboru, Terada Takaho, Hirata Kunio, Kawano Yoshiaki, Yamamoto Masaki, Tomita Taisuke, Ishibashi Yohei, Hirabayashi Yoshio, Kimura-Someya Tomomi, Shirouzu Mikako, Yokoyama Shigeyuki
RIKEN Systems and Structural Biology Center, Yokohama 230-0045, Japan.
Division of Structural and Synthetic Biology, RIKEN Center for Life Science Technologies, Yokohama 230-0045, Japan.
Sci Rep. 2016 Jul 28;6:30442. doi: 10.1038/srep30442.
The crystal structures of four membrane proteins, from bacteria or a unicellular alga, have been solved with samples produced by cell-free protein synthesis. In this study, for mammalian membrane protein production, we established the precipitating and soluble membrane fragment methods: membrane proteins are synthesized with the Escherichia coli cell-free system in the presence of large and small membrane fragments, respectively, and are simultaneously integrated into the lipid environments. We applied the precipitating membrane fragment method to produce various mammalian membrane proteins, including human claudins, glucosylceramide synthase, and the γ-secretase subunits. These proteins were produced at levels of about 0.1-1.0 mg per ml cell-free reaction under the initial conditions, and were obtained as precipitates by ultracentrifugation. Larger amounts of membrane proteins were produced by the soluble membrane fragment method, collected in the ultracentrifugation supernatants, and purified directly by column chromatography. For several proteins, the conditions of the membrane fragment methods were further optimized, such as by the addition of specific lipids/detergents. The functional and structural integrities of the purified proteins were confirmed by analyses of their ligand binding activities, size-exclusion chromatography profiles, and/or thermal stabilities. We successfully obtained high-quality crystals of the complex of human claudin-4 with an enterotoxin.
通过无细胞蛋白质合成产生的样品,已解析出四种来自细菌或单细胞藻类的膜蛋白的晶体结构。在本研究中,为了生产哺乳动物膜蛋白,我们建立了沉淀膜片段法和可溶性膜片段法:膜蛋白分别在大肠杆菌无细胞系统中,于存在大、小膜片段的情况下合成,并同时整合到脂质环境中。我们应用沉淀膜片段法生产了多种哺乳动物膜蛋白,包括人闭合蛋白、葡糖神经酰胺合酶和γ-分泌酶亚基。在初始条件下,这些蛋白在每毫升无细胞反应中以约0.1 - 1.0毫克的水平产生,并通过超速离心作为沉淀获得。通过可溶性膜片段法生产了更多量的膜蛋白,收集在超速离心上清液中,并直接通过柱色谱法纯化。对于几种蛋白,膜片段法的条件进一步优化,例如通过添加特定的脂质/去污剂。通过分析纯化蛋白的配体结合活性、尺寸排阻色谱图谱和/或热稳定性,证实了其功能和结构完整性。我们成功获得了人闭合蛋白-4与一种肠毒素复合物的高质量晶体。